✦ LIBER ✦

Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model

✍ Scribed by Guru Sonpavde; Weiguo Jian; Hao Liu; Meng-Fen Wu; Steven S. Shen; Seth P. Lerner

Book ID: 116956302
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 733 KB
Volume: 27
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2008.03.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sunitinib Malate Provides Activity Again

Sunitinib Malate Provides Activity Against Murine Bladder Tumor Growth and Invasion in a Preclinical Orthotopic Model

✍ Eddie Shu-yin Chan; Amit R. Patel; Donna E. Hansel; William A. Larchian; Warren 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 596 KB

Re: Sunitinib Malate Provides Activity a

Re: Sunitinib Malate Provides Activity against Murine Bladder Tumor Growth and Invasion in a Preclinical Orthotopic Model

✍ Wood, David P. 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 94 KB

Preclinical activity of a new platinum a

Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines

✍ Andreas Harstrick, Carsten Bokemeyer… 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 456 KB

Doxorubicin Activity Is Enhanced by Hype

Doxorubicin Activity Is Enhanced by Hyperthermia in a Model of Ex Vivo Vascular Perfusion of Human Colon Carcinoma

✍ Pierluigi Pilati; Simone Mocellin; Carlo R. Rossi; Romano Scalerta; Rita Alaggio 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 120 KB

Preconditioning chemotherapy with paclit

Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced-killer cells in a murine lung carcinoma model

✍ Xiang Huang; Guichun Huang; Haizhu Song; Longbang Chen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 718 KB

## Abstract Adoptive cell therapy involving the use of __ex vivo__ generated cytokine‐induced killer cells (CIKs) provides a promising approach to immunotherapy. However, the therapeutic activity of CIKs is limited by the immunosuppressive factors active in the host. It has become increasingly appa

Preclinical PK/PD modeling and human eff

Preclinical PK/PD modeling and human efficacious dose projection for a glucokinase activator in the treatment of diabetes

✍ Zager, Michael G.; Kozminski, Kirk; Pascual, Bernadette; Ogilvie, Kathleen M.; S 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 371 KB